Skip to main content
Clinical Trials/NCT02333266
NCT02333266
Withdrawn
Not Applicable

Bio-assay Development and Implementation for Fungal Infection Detection

ConditionsCandidemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Candidemia
Sponsor
Universitaire Ziekenhuizen KU Leuven
Primary Endpoint
Detection of Candida albicans with the newly developed FUNGDETECT sensor in blood samples from patients with candidemia due to Candida albicans
Status
Withdrawn
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to determine whether the newly developed biosensor can be used to detect and quantify fungal cells in human blood samples.

Detailed Description

The study discussed here is part of a broader research project (IOF project) that is aimed at the development and implementation of a point-of-care devices, in which Fiber-Optic Surface Plasmon Resonance (FO-SPR) is used as a detection system. This project includes the development and implementation of the (FUNGDETECT) sensor for fast and accurate detection of fungal pathogens in human blood samples. In first instance, the sensor will be tested in buffer solutions spiked with a known amount of Candida albicans cells. Further validation of the prototype includes detection of these cells in human blood samples. In a first experiment, detection of yeast cells will be performed in blood samples from 5 healthy volunteers each spiked with yeast cells from different Candida spp.. A second experiment includes the detection in blood samples from 15 patients who suffer from a candidemia. The blood samples will be collected from patients of University Hospitals (UZ) Leuven.

Registry
clinicaltrials.gov
Start Date
June 2016
End Date
December 2017
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy volunteers for validation of the (FUNGDETECT) sensor (Spiked blood samples)
  • Candidemia

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Detection of Candida albicans with the newly developed FUNGDETECT sensor in blood samples from patients with candidemia due to Candida albicans

Time Frame: Blood samples will be collected at baseline from patients directly after informed consent is given

Patients in the hospital and suspected to have a Candida infection will be tested for Candida infections via blood cultures. Blood samples for patients with a positive test will be taken immediately after the positive result and used to validate the FUNGDETECT sensor.

Similar Trials